carboplatin, paclitaxel

DRUG3 trials

Sponsors

Valerio Therapeutics, Karolinska University Hospital, First Affiliated Hospital of Ningbo University

Conditions

Carcinoma of Unknown PrimaryEsophageal Squamous Cell CarcinomaII-IIIB StagesLocally Advanced Esophageal Squamous Cell Carcinoma

Phase 2

Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary

CompletedNCT00873119

Valerio TherapeuticsCarcinoma of Unknown Primary

Start: 2009-02-28End: 2012-12-31Updated: 2015-07-28

Phase 3

Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer

RecruitingNCT04460352

Karolinska University HospitalEsophageal Squamous Cell Carcinoma

Start: 2020-11-27End: 2031-12-31Target: 1020Updated: 2025-03-06

Unknown Phase

Efficacy and Safety of Cadonilimab and Chemoradiotherapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma

Enrolling by invitationNCT06715501

First Affiliated Hospital of Ningbo UniversityII-IIIB Stages, Locally Advanced Esophageal Squamous Cell Carcinoma

Start: 2024-12-01End: 2027-09-01Target: 20Updated: 2025-03-25

Related Papers

Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS Trial

Frontiers in Oncology2022-07-1329 citations